Senator Rosen supported passing the Inflation Reduction Act, which implemented a $35 monthly cap on out-of-pocket insulin costs for seniors on Medicare Part D. The cap went into effect in January 2023 and the law is now helping Nevadans like Berman save money on life-saving medication.
The provision, signed into law by President Biden, will significantly lower out-of-pocket drug costs for many of the over 427,000 Nevada seniors enrolled in Medicare Part D coverage.
EXCLUSIVA: La senadora Jacky Rosen lidera el esfuerzo para asegurar beneficios a 310 mujeres excombatientes
Jacky Rosen, senadora federal por Nevada, solicita que el gobierno federal corrija los errores en sus registros militares para garantizar que las excombatientes que sirvieron en Afganistán e Irak sean elegibles para recibir los beneficios a los que se hicieron acreedoras por su heroico trabajo.
Starting in 2026, the prices for these drugs will decrease for up to nine million seniors, thanks to a provision in President Biden’s Inflation Reduction Act that allows Medicare to negotiate the prices for these drugs directly with the manufacturers.
The law ensured that 21,000 Nevadans were able to keep their health insurance, reduced the cost of insulin for nearly 11,000 seniors, and incentivized several manufacturers to invest in the state and create more clean energy jobs.
The PUMP for Nursing Mothers Act extends the right to pump breast milk to more workers and emphasizes the need for private spaces other than a bathroom to do so.
As the one year anniversary of the Inflation Reduction Act approaches, Rosen visited Unimacts, a clean energy manufacturing company, which has been able to take advantage of several tax credits afforded by the law to expand its operations into Nevada and increase revenue.
President Joe Biden announced new steps to improve mental health care in America. The new rule would require private health insurance companies to offer the same level of mental health benefits that they offer for physical health benefits
Opill is the first ever birth control pill to be approved for over-the-counter sales. The medication will likely become available at stores and online retailers in the U.S. in early 2024.